Downregulation of VEGF expression in tumor tissues and decreased secretion of serum VEGF were found in xenograft mouse models of melanoma, breast cancer, and pancreatic cancer treated with ascorbate 57, 58. This evidence concerns the gene VEGFA and breast cancer.